Eli Lilly cut prices of its Zepbound drug single-dose vials on its direct-to-consumer platform after it lowered prices of its multi-dose pens last month.
The 2.5 milligram starting dose of Zepbound will now be available for $299 a month, down from $349. The 5 milligram dose will cost $399 a month, compared with its previous price of $499.
The 7.5 milligram, 10 milligram, 12.5 milligram and 15 milligram doses will all now cost $449, down from $499.
The lower prices are available for Eli Lilly's Zepbound Self-Pay Journey Program via its LillyDirect digital platform.
In November, the company made a deal with the U.S. government that included an agreement to lower prices of its Zepbound multi-dose pen.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.